ABSTRACT Introduction
INTRODUCTION
The introduction of standardized clinical decision rules (CDRs) to determine the clinical probability of pulmonary embolism (PE) has made a large improvement in the diagnostic workup of patients with suspected PE. A CDR used in combination with a normal D-dimer test result can exclude the diagnosis of PE in a large proportion of patients (20-40%) without the need for additional imaging with computed tomographic pulmonary angiography (CT) or ventilation-perfusion scintigraphy, which both involve radiation and intravenous contrast. In these patients anticoagulants can be safely withheld (1) (2) (3) (4) . Several clinical decision rules have been derived and validated. The Wells rule is composed of seven variables obtained from medical history and physical examination (Table 1 ) (5) . One of the variables is a subjective variable: the physician should consider the possibility of an alternative diagnosis for the patient's complaints. In contrast, the more recently introduced Revised Geneva Score is composed of eight more objective clinical variables obtained from medical history and physical examination (6) . Both scores assign different weights to the variables. Because miscalculations can occur, the scores have recently been simplified: the simplified Wells rule and the simplified revised Geneva score assign one point to all items (with the exception of the heart rate in the simplified revised Geneva score, in which one point was assigned to a heart rate of 75 beats per minute or more and one additional point if the heart rate exceeds 94 beats per minute) (Table 1) (7, 8) . Until now, the simplified Wells rule and the simplified revised Geneva score have not been validated prospectively. Also, while some of the scores have retrospectively or prospectively been compared with each other (9) (10) (11) (12) , the four scores have never been directly compared for safety and clinical utility of excluding PE in combination with a D-dimer test. Therefore, we performed a prospective multi-center clinical accuracy study to assess and directly compare the performance of these four different CDRs (Wells rule, revised Geneva score, simplified Wells rule and simplified revised Geneva score) in excluding PE in combination with D-dimer testing with respect to safety and clinical utility, using a computer-based "black-box" principle for calculation of the CDR scores.
PATIENTS AND METHODS
The study was a prospective multi-center cohort study of consecutive patients with a suspected first episode of acute pulmonary embolism.
Study patients
The study population consisted of consecutive inpatients and outpatients, in whom acute pulmonary embolism was suspected. This was defined as sudden onset of dyspnea, deterioration of existing dyspnea and/or sudden onset of pleuritic chest pain. Patients were Exclusion criteria were age below 18 years of age, life expectancy of less than 3 months, treatment with therapeutic-dose low molecular weight heparin or unfractionated heparin that was initiated 24 hours or more prior to eligibility assessment, treatment with vitamin K antagonists, contraindication to helical CT scan because of allergy to intravenous iodinated contrast or renal insufficiency (creatinine clearance < 30 ml/min using the Cockroft-Gault formula), pregnancy and inability to return for follow-up. Institutional ethical review boards of all participating hospitals approved the study protocol and informed consent was obtained from all included patients.
Study flow
Consecutive patients with a clinical suspicion of first PE were asked to participate in the study. They underwent a sequential work-up of clinical probability assessment, D-dimer testing and CT scanning. In all patients, the items for the four clinical decision rules were assessed: the Wells rule, simplified Wells rule, Revised Geneva score and the simplified Revised Geneva score (see Table  1 ). In addition, a high-sensitivity quantitative D-dimer test was performed (VIDAS D-dimer assay, Biomerieux, Marcy L'Etoile, France; Tinaquant assay, Roche Diagnostica, Mannheim, Germany; STA-Liatest D-Di, Diagnostica Stago, Asnieres, France; or Innovance D-dimer, Siemens, Marburg, Germany), depending on local practice. Pulmonary embolism was considered "unlikely" in case of a Wells rule of 4 points or less, a simplified Wells rule of 1 point or less (7, 10) , and a simplified revised Geneva score with a score of 2 points or less (8) ( Table  1 ). The revised Geneva score, until now only available in a three-category scheme, was transformed to a two-category scheme similar to the other scores. This was done by a beforehand calculation of the optimal cut-off, using an existing cohort of patients (8) with suspected PE for whom the revised Geneva score variables were available for calculation of the score (unpublished data). Based on this calculation, PE was considered "unlikely" with a score of 5 points or less (Table 1) . For any of the CDRs, a score above the respective cut-off indicated "PE likely". When PE was considered "unlikely" according to all four CDRs in combination with a normal Ddimer test result (cut-off < 500 μg/L), pulmonary embolism was excluded. In all remaining patients (i.e. a "likely" result according to at least one of the CDRs or an abnormal D-dimer test result), CT scanning was indicated to confirm or exclude the diagnosis. Treatment was withheld from patients in whom the diagnosis was excluded, and these patients were followed for a 3-month period. The study flow is illustrated in Figure 1 .
Imaging protocols
Standard contrast enhanced MDCT was performed using a 4-slice, 16-slice, or 64-slice MDCT scanner with acquisition of 0.5 or 1 mm sections (depending on the weight of the subject) of the entire chest for diagnosing or excluding PE. The rotation time was 0.4 s with a pitch factor of 1.4; the tube current was 250-300 mA and the tube voltage 100 kV. Acquisitions were performed during a single breath-hold, lasting 10-12 seconds or less, depending on the type of scanner. 80-100 ml of contrast agent was injected in the antecubital vein with an injection rate of 4.0 ml/sec. The acquisition of the static pulmonary angiography scan was started after automated threshold enhancement detection in the pulmonary trunk. A threshold difference of 100 Hounsfield units was selected for starting the acquisition. The diagnosis of PE was confirmed by the presence of at least one filling defect in the pulmonary artery tree. Management of patients with an inconclusive CT result was left to the attending physician and could include repeat CT scanning, ventilation-perfusion scintigraphy or conventional pulmonary angiography. 
Follow-up
Patients, in whom PE was excluded either based on the CDR/D-dimer combination (for all four CDRs) or based on a normal CT, were followed up for 3 months. All patients were instructed to return to the hospital should complaints of venous thromboembolism (PE or DVT) or bleeding occur. Objective diagnostic tests were performed if a suspicion of VTE was raised: e.g. CTscanning, V/Q-scanning and/or compression ultrasonography. Patients were interviewed by telephone by one of the study coordinators at the end of a three months follow-up period and were questioned on health-related events during the past three months, especially for symptoms suggestive of PE (i.e. acute shortness of breath, acute worsening of shortness of breath, acute onset of chest pain) or DVT (i.e. unilateral leg swelling and leg pain), interval initiation of anticoagulants and possible haemorrhagic complications. If relevant, the patient's general practitioner was contacted for additional information. If a patients had died, the cause of death was information was obtained from hospital records, the general practitioner or from from autopsy reports. Deaths were classified as due to pulmonary embolism in case of confirmation by autopsy, an objective diagnostic test positive for PE prior to death, or if the cause of death could not completely be explained by reasons other than VTE. All outcomes were adjudicated by a panel of three experts, who were blinded for the clinical conditions of the patients.
Statistical analysis
In this study, the four CDRs were directly compared for their safety and clinical utility. This included four primary analyses: 1) the ability of each CDR to correctly categorize patients with suspected PE as "unlikely" or "likely"; 2) the clinical utility, defined as the proportion of patients in whom the diagnosis could be excluded based on an "unlikely" CDR combined with a normal D-dimer test; 3) the safety of each CDR-D-dimer combination to exclude the diagnosis, based on the failure rate. The latter was defined as the VTE rate during the 3-month follow-up in patients in whom PE was considered ruled out by the initial diagnostic work-up and who did not receive anticoagulants during follow-up; 4) discordant cases (patients classified as "unlikely" by one CDR but "likely" by another) were studied. The outcome of CT scanning and 3 month follow-up in patients with normal tests was the reference standard.
Also, since the revised Geneva rule was designed and is currently used in a three-category scheme (6,13), we also calculated the outcomes of the CDRs for the three-category schemes of the decision rules. These results are available in the Appendix. To detect a difference of more than 5% in sensitivity among the two primary CDRs (i.e. Wells and revised Geneva score) the sample size must contain 753 participants with a suspected pulmonary embolism. All additional sample size calculations on other outcomes needed a smaller sample size. Because of possible dropout, we aimed for a total sample size of 800 patients. Exact 95% confidence intervals (CI) were calculated around the observed incidences using Confidence Interval Analysis (CIA, version 1.0; Gardner MJ). Descriptive parameters were calculated using SPSS software, version 16.0 (SPSS Inc, Chicago, Ill). For statistical differences, χ2-test and McNemar's test were used; statistical significance was set at p<0.05.
RESULTS

Study patients
A total of 1023 consecutive patients with clinically suspected pulmonary embolism were screened, of whom 195 (19%) were excluded because of one or more of the predefined exclusion criteria (previous PE (n=82), treatment with vitamin K antagonists (n=31), more than 24 hours of low-molecular-weight heparin (n=20), impossibility for follow-up (n=19), pregnancy (n=18), renal insufficiency (n=14), life expectancy less than 3 months (n=12), and allergy to intravenous contrast agent (n=4)). In addition, 21 patients refused to give informed consent.
The final study population of 807 participants included 644 (80%) outpatients and 163 (20%) inpatients. The baseline demographic and clinical characteristics of the 807 study participants are shown in Table 2 .
Result of Diagnostic Algorithm
Of the 807 included patients, the result of the CDR was "unlikely" according to all four CDRs in 434 (54%) patients ("all-unlikely" group). D-dimer test was normal in 169 of these 434 patients.
As a result, in 169/807 (21%) of the patients PE was ruled out by a combination of an "unlikely" CDR result according to all four CDRs and a normal D-dimer test result. In 264 of the 434 patients, the D-dimer test was abnormal. In one additional patient, the D-dimer test was not performed (protocol violation). These 265 patients underwent CT scanning ( Figure 1 ). The result of the CDR was "likely" according to all four CDRs in 130 of 807 (16%) patients ("alllikely" group) and was discordant in 243 of 807 (30%) patients ("discordant" group, see Figure  1 ). According to the protocol, a CT scan was indicated in 638 of 807 (79%) patients: 265 patients with an "all-unlikely" CDR result but an abnormal D-dimer test; 243 patients from the discordant group; and 130 patients with an "all-likely" CDR result. However, in nine of them CT scanning was not performed (protocol violations), they were followed for three months. CT confirmed the diagnosis of PE in 184 patients ( Figure 1 ). The diagnosis was excluded in 435 patients, of whom an alternative diagnosis for the complaints was found in 164. CT was inconclusive in 10 patients: repeat CT scanning excluded the diagnosis in two of these patients, and ventilation/perfusion scintigraphy excluded the diagnosis in two other patients. In one patient, anticoagulant treatment was started based on an inconclusive CT scan combined with high clinical suspicion of PE and in another, thrombosis of the subclavian vein was found with the same scan; these patients were treated accordingly. In the remaining 4 patients with inconclusive CT scans, the diagnosis was considered to be excluded without further testing and as a result, these patients were not treated with anticoagulant medication. The overall prevalence of PE in of this study population was therefore 184/807 (23%, 95% CI: 20% to 26%).
Follow Up
In seven patients of the 169 patients in the all-unlikely group who had a normal D-dimer, the protocol was violated and a CT scan was performed while not indicated; in one of these patients, PE was diagnosed (failure rate in the non-CT group 1/169; 0.6%, 95% CI: 0.02% to 3.3%) (Figure 1 ; patient number 1 in Table 3 ). None of the remaining patients in this group were treated with anticoagulants during follow-up and all of these patients had an uneventful follow-up. The nine patients, in whom a CT scan was indicated but not performed, were also left untreated and had an uneventful follow-up. Of the 435 patients in whom PE was excluded with CT scanning and the eight remaining patients with inconclusive results, 10 patients (2.3%) were treated with anticoagulants during follow-up for reasons other than VTE. Seven of the remaining 433 patients with a normal CT scan result returned with symptomatic and objectively confirmed VTE events during the 3-month follow up (Figure 1 ; patient numbers 2 to 8 in Table 3 ). Eighteen patients died during follow-up. In one of these patients, a DVT had already been diagnosed during follow-up; in another patient PE was excluded by autopsy as cause of death; while in the remaining 16 patients, the cause of death was clinically regarded to be unrelated to a possible VTE. Therefore, the failure rate of a normal CT in this study was 7 in 433 (1.6%, 95% CI: 0.7% to 3.3%). One patient (1/807, 0.1%) was lost to follow-up. In a "worst case" scenario, in which this patient would have developed VTE, the failure rate after CT-scanning that excluded PE would have been 8 in 433 (1.9%, 95% CI: 0.8% to 3.6%).
Categorization of patients in probability groups with the four CDRs Table 4 describes how the patients were categorized by the two probability categories of the four CDRs. There was no difference in the distribution of patients between the scores and the prevalence of PE in the "unlikely" categories was comparable. Overall, the proportion of patients classified as "likely" was largest using the simplified Wells: 38% versus 28% to 32% with the other three CDRs. The sensitivity and specificity of the CDRs differed between the four rules and ranged from 51% to 65% (sensitivity) and from 70% to 80% (specificity), respectively (Table 5a ). Figure 2 shows the Receiver Operator Characteristics-curves for the four CDRs. These were comparable and showed similar areas under the curve, ranging from 0.694 to 0.734 (no significant differences).
Safety and clinical utility of the four CDRs
Combined with a normal D-dimer, the four CDRs excluded PE in similar proportions of patients, ranging from 22% to 24% (Table 4 ). There was no difference between the three month VTE failure rates of the different CDR-D-dimer combinations. This failure rate ranged from 0.5% to 0.6% (Table 4 ). The 95% CI ranged from a lower level of 0.02% for all rules to an upper level of 3.0% for the Wells rule, 3.1% for the simplified Wells rule, 3.0% for the revised Geneva score, and 2.9% for the simplified revised Geneva score, respectively (Table 4) . When combined with the D-dimer test result, the sensitivities of the various CDRs did not differ, while there were small differences in specificity (Table 5b) . RGS, revised Geneva rule; CI, confidence interval; NPV, negative predictive value; PE, pulmonary embolism. Sensitivities did not differ between the four CDRs. Specificity was significantly different between the Wells rule and the simplified Wells rule (p=0.031) and the simplified Wells rule and simplified RGS (p=0.017).Other differences in specificity were not statistically significant.
Discordance between the CDRs
The four CDRs were discordant in their classification of "unlikely" or "likely" in 243 of 807 patients (30%) (Figure 1 ). In 29 (12%) of these patients the D-dimer was normal, and 196 (81%) patients had an abnormal D-dimer test result, whereas the D-dimer test was not performed in 18 patients (7.4%). In the latter patients, CT-scanning was performed, which confirmed the diagnosis in one patient. Table 6b . Discordances between the categorization in "unlikely" and "likely" clinical probability groups according to four clinical decision rules in 205 patients with suspected pulmonary embolism and a normal D-dimer test result. In total, 29 patients had discordant clinical decision rule results.
Wells "likely"
SW "likely"
RGS "likely"
SRGS "likely" (n=15) n n with PE n n with PE n n with PE n n with PE Wells "unlikely" Table 6a shows the discordances between patients with an "unlikely" CDR result according to one score in spite of a "likely" CDR result according to another score. The number of discordant cases between two scores differed and ranged from 25/807 (3.1%) between the revised Geneva score and the simplified revised Geneva score, to 199/807 (25%) between the Wells rule and the revised Geneva score (see Table 6a : 24+1 discordant cases and 84+115 discordant cases, respectively). The agreement was greatest between the original scores (Wells, revised Geneva score) and their simplified versions (simplified Wells and simplified revised Geneva score; discordance 11% and 3.1%, respectively), while discordance was above 20% between all other scores. Despite the discordant scores, PE was not missed in any of the patients from the discordant group who had a normal D-dimer (Table 6b) . Therefore, the scores were equally safe in ruling out PE when combined with the D-dimer. Of note, in one of the patients that developed VTE during the follow up period, the diagnosis had first been excluded based on discordant CDRs, a missing D-dimer test and a normal CT-scan (patient number 7 in Table 3 ).
Additional observations
Four different D-dimer assays were used: the Tinaquant assay was performed in 65 patients (8.1%); the VIDAS assay in 182 patients (22%); the Innovance assay in 308 patients (38%) and the STA-Lia assay in 212 patients (27%), respectively. The D-dimer was not performed in 40 patients (5.0%). Between the various CDRs, no differences in the exclusion rate per D-dimer were observed (data not shown). Both inpatients and outpatients were included in the study. The failure rate of excluding PE based on an "unlikely" CDR and normal D-dimer was similar for both inpatients and outpatients with all four CDRs (data not shown). However, the proportion of inpatients in which PE could be excluded non-invasively was very low: only four inpatients (4/163 inpatients, 2.5%).
DISCUSSION
This accuracy study directly compared four CDRs for the probability assessment of pulmonary embolism and showed that the CDRs are similar in 1) their ability to categorize patients in an "unlikely" and "likely" clinical probability group; 2) the clinical utility of ruling out pulmonary embolism based on an "unlikely" CDR result and a normal D-dimer test; and 3) the safety of ruling out PE based on the CDR and D-dimer combination. Importantly, although discordances in the categorization of patients in an "unlikely" or "likely" group by the scores were present in 30% of the patients, this did not result in a difference in failure rates when the CDR was combined with the D-dimer.
Our results are important and relevant for clinical practice. The Wells rule with its incorporated subjective variable of whether or not an alternative diagnosis is as likely as PE is often debated. However, in this comparison, the Wells rule and simplified Wells rule showed to be equivalent in performance compared to the fully objective revised Geneva score. The Wells rule and the revised Geneva score have a drawback since they assign different weights to the variables making up the scores. Additional to the comparison of these two rules, we were able to validate the accuracy and clinical utility of the recently introduced simplifications of the Wells rule and revised Geneva score. Both simplified scores had similar diagnostic performance to their original and extensively validated versions, although the upper confidence interval level was slightly above 3% for the simplified Wells rule, which can most probably be attributed to the modest sample size. The importance of clinical probability estimation has been emphasized on many occasions (14) (15) (16) (17) (18) . Although the D-dimer is a sensitive assay in the diagnosis of PE, false negative results are more likely to occur when the pre-test clinical probability is high (18) . This prospective validation of the simplified CDRs has relevant practical implications, for they enable easier computation of the clinical probability score, which in turn could lead to better implementation of CDR use in daily clinical care. In fact, with the simplified Wells rule, "computation" is not even necessary: if there is no or only one criterion present, a normal D-dimer test will exclude the diagnosis. In all other cases, CT scanning is necessary. Therefore, only the Wells criteria need to be remembered, not the different point scores.
Our findings are in line with previous studies using these CDRs in a two-category scheme (14) . With the Wells rule, 51-84% of patients were categorized as "unlikely" in previous reports, with prevalence of PE ranging from 3.4-12%, compared to 72% and 15% in this study, respectively. Using the simplified Wells rule, the proportion of "PE unlikely" patients was slightly lower in our cohort (62%) compared to a previous validation study (78%), but prevalence of PE in this "unlikely" group was comparable (13% in both studies) (10) . Similarly, in an earlier retrospective study, the simplified revised Geneva score classified 65% of the patients as "unlikely" compared to 62% in the current analysis, with PE prevalence of 13% and 16% in our study, respectively (8) . As this is the first study to report of a two-category scheme for the revised Geneva score, we cannot compare our data of the two-category revised Geneva score with previous findings. However, the 69% patients with an "unlikely" CDR result as well as the 16% prevalence of PE overlap well with the results from the other three decision rules.
Four highly sensitive but different D-dimer assays were used. Because the CDRs were determined in all patients, the types of D-dimers assays were equally represented in the different CDR groups, which enables comparison of the CDRs irrespective of the D-dimer assay. Type of assay was not based on randomization, but was dependent on the preference of the study center. Unfortunately, therefore, comparisons between the various D-dimer assays are limited by the sample sizes.
After several retrospective or small prospective comparisons, this is the first large study to directly compare the most widely used CDRs in the diagnostic management of PE. Furthermore, this study prospectively validated the performance of the recently introduced simplified Wells rule and simplified revised Geneva score. Calculation of the scores in all patients allowed a direct comparison of the CDRs in a single patient population. Also, due to the computer-aided design of the study, calculation errors were minimized. Likewise, this use of a black-box excluded the possibility of allowing the physician's preference for a certain CDR to influence the management of a patient.
Several potential limitations of our study, however, require comment. The strength of our study is the use of a computer programme that restricted patients to be managed directly according to the outcome of the individual CDR -D-dimer combinations. A randomized controlled trial between the four CDRs is an alternative study design, but in view of the reasonably high concordance rates would have been very inefficient. In addition, by study design, CT scans were performed in all patients with discordant CDRs and ensured that an imaging diagnosis was available in all those patients. Second, the diagnostic protocol was violated in eight patients, in whom CT was not performed despite discordance of the CDRs. Three-month follow-up, however, was uneventful in these patients. Use of a computerized decision-support system improves the diagnosis of pulmonary embolism (19) . However, in daily clinical practice, these systems may not be widely available and our results may therefore differ from a setting in which more miscalculations are possible. There are several arguments for the results of our study to be applicable in a wide range of clinical settings. First, the clinical characteristics of the patients in the study are comparable with those in other population-based studies (2, 4, 13) , and the 23% prevalence of PE in this cohort is comparable to other reports (2, 4, 6) . Second, consecutive patients were included from both academic and non-academic medical centers. Finally, patients with suspected recurrent PE were not included, so the performance of the CDRs in this group will need additional study.
In conclusion, the Wells rule, the revised Geneva score, the simplified Wells rule as well as the simplified revised Geneva score, in combination with a D-dimer test, show similar safety and clinical utility for excluding PE. Furthermore, with this prospective validation, the more straightforward simplified decision rules are ready for use in clinical practice. Which rule a physician will use should depend on local preference and acquaintance, in order to accomplish correct use of the CDR and prevent miscalculations.
APPENDIX
Distribution of patients with suspected pulmonary embolism categorized into a three-category scheme by four clinical decision rules for pulmonary embolism: the Wells rule, the simplified Wells rule, the revised Geneva score and the simplified revised Geneva score.
In the Prometheus Diagnosis study, four clinical decision rules (CDRs) were compared for the safety and clinical utility of excluding pulmonary embolism: the Wells rule (1), the simplified Wells rule (2), the revised Geneva score (RGS) (3) and simplified RGS (4). All scores were studied in a two-category scheme, which categorizes patients into "PE unlikely" and "PE likely". The revised Geneva rule, however, was designed and is currently used in a three-category scheme. To give further insight into the distribution of patients categorized by these four scores in three-category schemes, we calculated the outcomes of the CDRs for "low", "intermediate" and "high" probability categories. Using three probability categories, the proportions of patients in the "low", "intermediate" and "high" probability categories were comparable for the Wells rule, the RGS and the simplified RGS (Table 2) . With the simplified Wells rule, however, patients were more often classified as having a low or high probability compared to the other three rules.
For all four rules the results using a three-category distribution are in line with previous studies with three-category scheme CDRs (3-11).
